chelerythrine has been researched along with Brain Neoplasms in 1 studies
chelerythrine : A benzophenanthridine alkaloid isolated from the root of Zanthoxylum simulans, Chelidonium majus L., and other Papaveraceae.
Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhu, M | 1 |
| Niu, J | 1 |
| Jiang, J | 1 |
| Dong, T | 1 |
| Chen, Y | 1 |
| Yang, X | 1 |
| Liu, P | 1 |
1 other study available for chelerythrine and Brain Neoplasms
| Article | Year |
|---|---|
Chelerythrine inhibits the progression of glioblastoma by suppressing the TGFB1-ERK1/2/Smad2/3-Snail/ZEB1 signaling pathway.
Topics: Animals; Antineoplastic Agents; Benzophenanthridines; Brain Neoplasms; Cell Line, Tumor; Cell Surviv | 2022 |